Clinical Trials in Egypt / NCT07236697
Starting soon
Observational
Impact of Subclinical Hypothyroidism on Liver Enzymes and Lipid Profile
NCT07236697 · tracked via the Priya Life Science Egypt tracker
Condition(s) studied
Subclinical Hypothyroidism
Investigational drug(s) / intervention(s)
liver enzymes
liver enzymes: subclinical hypothyroidism on liver enzymes and lipid profile
Study summary
the goal of the randomized controlled observational study is to observe the effect of subclinical hypothyroidism on liver enzymes and lipid profile
Eligibility
Inclusion Criteria:
* • Age ≥ 18 years
* For SCH group: Elevated TSH with normal FT4
* For control group: Normal TSH and FT4 levels
Exclusion Criteria:
* • Evident hypothyroidism or hyperthyroidism
* Diagnosed with diabetes mellitus
* Chronic liver disease
* Chronic kidney disease
* Use of lipid-lowering or thyroid medications
* Pregnancy
* Alcohol abuse
Primary outcome measure(s)
- Impact of Subclinical Hypothyroidism on Liver Enzymes and Lipid Profile — Baseline
1. Mean levels of liver enzymes (ALT, AST, GGT) • To determine whether there is a statistically significant difference in liver enzyme levels between individuals with subclinical hypothyroidism and euthyroid controls. 2. Mean values of lipid profile components (Total Cholesterol, LDL-C, HDL-C, Triglycerides) • To assess whether subclinical hypothyroidism is associated with dyslipidemia compared to the control group.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Assiut university hospitals | Asyut | Egypt |
More Assiut University trials in Egypt
The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion
Starting soon
Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores
Starting soon
Real-Time (TRUS) Guidance in Endoscopic Treatment of BPH
Starting soon
Intraoperative Lidocaine Infusion
Starting soon
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07236697 on ClinicalTrials.gov ↗ ← All trials in Egypt